Showing results (261-270 of 418) with videos related to

Sort By:
Pageof 42
Current Drug Targets|November 3, 2010
ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosisDan Ye, Bart Lammers, Ying Zhao, et al.
The Biochemical Journal|April 1, 1994
Ligand size is a major determinant of high-affinity binding of fucose- and galactose-exposing (lipo)proteins by the hepatic fucose receptorE A Biessen, H F Bakkeren, D M Beuting, et al.
European Journal of Biochemistry|November 18, 2000
Purification and properties of hydroquinone hydroxylase, a FAD-dependent monooxygenase involved in the catabolism of 4-hydroxybenzoate in Candida parapsilosis CBS604M H Eppink, E Cammaart, D Van Wassenaar, et al.
Pharmaceutical Research|May 20, 1998
Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapyA J Versluis, E T Rump, P C Rensen, et al.
Atherosclerosis|December 1, 1995
LDL receptor-independent and -dependent uptake of lipoproteinsT J van Berkel, K Fluiter, A G van Velzen, et al.
Analytical Chemistry|June 10, 2021
Fluid Dynamics of the Open Port Interface for High-Speed Nanoliter Volume Sampling Mass SpectrometryChang Liu, Gary J Van Berkel, Peter Kovarik, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Midazolam is a phenobarbital-like cytochrome p450 inducer in ratsP A Hoen, M K Bijsterbosch, T J van Berkel, et al.
Biochemical Pharmacology|October 6, 2000
Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: analysis with a novel reverse transcriptase-polymerase chain reaction assay section signP A Hoen, J N Commandeur, N P Vermeulen, et al.
FEBS Letters|August 22, 2001
Tuning of the product spectrum of vanillyl-alcohol oxidase by medium engineeringR H van den Heuvel, J Partridge, C Laane, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1979
McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiencyJ F Koster, R G Slee, F G Jennekens, et al.
Pageof 42